Roche Diagnostics Scandinavia AB | Detailed information

Roche Diagnostics Scandinavia AB - Detailed information

Start page > Search result Company:R > Roche Diagnostics Scandinavia AB


Roche Diagnostics Scandinavia AB	Press releases from Newsdesk

Business ID:	556067-8194
Company:	Roche Diagnostics Scandinavia AB
Address:	Box 147
	SE-161 26 Bromma
Visiting address:	Karlsbodavägen 30
County:	Stockholms län
Telephone:	+46 (0)8-4048800
Fax:	Access required
E-mail:	Access required
Website:	Access required

Chairman of the board:	Access required
Managing Director/CEO:	Carlo Brot
Finances:	Access required
Marketing:	Access required
Purchasing Director:	Access required
IT:	Access required
Personnel:	Access required
Sales:	Access required

Established:

Access required

Subsidiary company to:

Access required

Stock-exchange listing:

Access required

Rank in the Nordic countries (incl. subsidiaries) by

Net turnover

Access required

Click for more rankings

Rank in the Nordic countries (incl. subsidiaries) by

[Close]

Net profit	Access required
Number of employees	Access required
Total assets	Access required

Industry sector:

B5146

Wholesale of pharmaceutical goods

Activity code:

51460

Wholesale of pharmaceutical goods

Rank in industry in the Nordic countries by :

Net turnover

Access required

Click for more rankings

Rank in industry in the Nordic countries by

[Close]

Industry sector:	B5146	Wholesale of pharmaceutical goods
Rank in industry in the Nordic countries by:
Total assets		Access required
Profitability		Access required
Solvency		Access required
Return on assets (ROA)		Access required
Net profit		Access required
Number of employees		Access required
Return on equity (ROE)		Access required

Closing information (x1000 EUR)
Fiscal year	200712	200612	200512
Net turnover	45.058	Access required	Access required
- exports	Access required	Access required	Access required
Foreign sales	Access required	Access required	Access required
Financial expenses	Access required	Access required	Access required
Earnings before taxes	Access required	Access required	Access required
Total assets	Access required	Access required	Access required
Current assets	Access required	Access required	Access required
Current liabilities	Access required	Access required	Access required
Equity capital	Access required	Access required	Access required
- share capital	Access required	Access required	Access required
Employees (average)	Access required	Access required	Access required
Shareholders	Access required	Access required	Access required
Investments in fixed assets	Access required	Access required	Access required

Financial ratios
Solvency	Access required	Access required	Access required
Turnover per employee	Access required	Access required	Access required
Earnings as % of turnover	Access required	Access required	Access required
Return on assets (ROA)	Access required	Access required	Access required
Current ratio	Access required	Access required	Access required
Return on equity (ROE)	Access required	Access required	Access required

Closing figures are converted from local currency to euros according to the exchange rate on closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from UC (Sweden), CreditInform (Norway), KOB (Denmark) and Asiakastieto (Finland).

Press releases from Newsdesk

Infarktrisk efter operation testas med biokemiska markörer

Kortare behandling med Pegasys ger samma goda effekt

Nytt klamydiatest från Roche godkänt för användning inom EU

Roche ger mer inom Genomsekvensering

Nu är nästa generations sekvenseringsteknologi här - Roche lanserar Genome Sequencer FLX-systemet.

Unga elitidrottare med diabetes belönas

Nordic Biosite distribuerar Roche Applied Science biokemikalier

Egenvård vid waranbehandling enligt nya riktlinjer

Hjärtsviktsmarkör ska mätas enligt nya riktlinjer

Självtest minskar risken med Waran